News

 

 

Clinical Trials

Jennifer Doherty
Assistant Professor
Cancer Epidemiology and Chemoprevention

  • NIH
    Epidemiologic factors and survival by molecular subtypes of ovarian cancer

Marc Ernstoff
Professor
Immunology and Cancer Immunotherapy

  • Bristol Myers Squibb
    A randomized, open-label multicenter Phase II study of ipilimumab tetreatment versus chemotherapy for subjects with advanced melanoma who progressed after initially achieving disease control with Ipilimumab Therapy